Lupin Q2 Preview: Profits may rise 42% YoY led by steady India, US sales

Quick Summary:

They anticipate the domestic business to grow by 10 per cent year-on-year, while the EMEA and ROW markets are expected to grow by 19 per cent and 15 per cent year-on-year, respectively.

Lupin is also expected to report a 43 per cent year-on-year growth in PAT for the last quarter.

Domestic sales are anticipated to grow by 11 per cent year-on-year, with EMEA and ROW markets expected to grow by 5 per cent and 4 per cent, respectively.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Lupin Q2 preview NIFTY 50 Markets Pharmaceuticals Sensex Q2 results Pharma sector Pharmaceuticals Pharma Generic Pharmaceuticals Stock market Lupin Lupin Q2

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-06 @ 10:00:46 (7 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 749 words

Reading Time: 5 minutes read

Sentences: 32 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23441436

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 292 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions